21 – Färskpressat: CRASH-3

Doktor Blund

Innhold levert av Anders Sillén. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Anders Sillén eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

4+ y ago 8:52

MP3•Episoder hjem

I dagarna publicerades CRASH-3 i Lancet. Den handlar om effekten av TXA (tranexamsyra) till patienter med traumatisk hjärnskada. Referenser CRASH-1 Olldashi, F., Muzha, I., Filipi, N., Lede, R., Copertari, P., Traverso, C., … Muñoz-Sánchez, A. (2004). Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): Randomised placebo-controlled trial. The Lancet. https://doi.org/10.1016/S0140-6736(04)17188-2 CRASH-2 CRASH-2 trial collaborators, Shakur, H., Roberts, I., Bautista, R., Caballero, J., Coats, T., … Yutthakasemsunt, S. (2010). Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet (London, England), 376(9734), 23–32. https://doi.org/10.1016/S0140-6736(10)60835-5 CRASH-3 Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. (2019). The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(19)32233-0

32 episoder

#Medicin #Anders Sillén #Fitness